{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:29:47Z","timestamp":1783531787197,"version":"3.55.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T00:00:00Z","timestamp":1429142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123938","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T17:58:30Z","timestamp":1429207110000},"page":"e0123938","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Graves\u2019 Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Susanna","family":"Leskela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodr\u00edguez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ramos-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sampedro-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"S\u00e1nchez-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gonz\u00e1lez-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Marazuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2004.02085.x","article-title":"Cellular immune responses in autoimmune thyroid disease","volume":"61","author":"AP Weetman","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jc.2011-0307","article-title":"Autoimmunity in Graves&apos; ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?","volume":"96","author":"WM Wiersinga","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves&apos; disease and ophthalmopathy","volume":"24","author":"BS Prabhakar","year":"2003","journal-title":"Endocr Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning &apos;sweet&apos; on immunity: galectin-glycan interactions in immune tolerance and inflammation","volume":"9","author":"GA Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.febslet.2012.07.032","article-title":"Immunoregulatory molecules are master regulators of inflammation during the immune response","volume":"586","author":"H de la Fuente","year":"2012","journal-title":"FEBS Lett"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/eji.200839177","article-title":"Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice","volume":"39","author":"FC Chou","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"M Seki","year":"2008","journal-title":"Clin Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200608-1243OC","article-title":"Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma","volume":"176","author":"S Katoh","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clim.2009.09.004","article-title":"Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages","volume":"133","author":"T Arikawa","year":"2009","journal-title":"Clin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"MA Toscano","year":"2007","journal-title":"Nat Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/path.1671","article-title":"Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response","volume":"204","author":"J van der Leij","year":"2004","journal-title":"J Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto&apos;s thyroiditis","volume":"95","author":"N Figueroa-Vega","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T cells in human autoimmune thyroid disease","volume":"91","author":"M Marazuela","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaut.2011.01.002","article-title":"Analysis of the cumulative changes in Graves&apos; disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors","volume":"36","author":"M Ruiz-Riol","year":"2011","journal-title":"J Autoimmun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves&apos; disease","volume":"186","author":"C Mao","year":"2011","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1210\/jc.2013-1273","article-title":"Plasmacytoid dendritic cells in patients with autoimmune thyroid disease","volume":"98","author":"S Leskela","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves&apos; orbitopathy (EUGOGO) on management of GO","volume":"158","author":"L Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1210\/jc.2008-1571","article-title":"Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features","volume":"94","author":"N Figueroa-Vega","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.intimp.2011.01.021","article-title":"Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: mechanisms and biomedical applications","volume":"11","author":"ID Mascanfroni","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G","article-title":"Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells","volume":"28","author":"C Blaser","year":"1998","journal-title":"Eur J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s001090050232","article-title":"Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death","volume":"76","author":"NL Perillo","year":"1998","journal-title":"J Mol Med (Berl)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1189\/jlb.1207831","article-title":"Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow","volume":"83","author":"D Cooper","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1096\/fj.07-9268com","article-title":"Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking","volume":"22","author":"LV Norling","year":"2008","journal-title":"FASEB J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation","volume":"409","author":"M Demetriou","year":"2001","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/art.23076","article-title":"Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts","volume":"56","author":"M Seki","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"L Monney","year":"2002","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1210\/en.2011-1579","article-title":"Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes","volume":"153","author":"M Kanzaki","year":"2012","journal-title":"Endocrinology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1189\/jlb.72.3.486","article-title":"Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells","volume":"72","author":"T Imaizumi","year":"2002","journal-title":"J Leukoc Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123938","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T14:30:13Z","timestamp":1691591413000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123938"}},"subtitle":[],"editor":[{"given":"Silke","family":"Appel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,16]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123938","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,16]]}}}